Results 111 to 120 of about 4,187 (189)
Background Monoacylglycerol lipase (MAGL) genes belong to the alpha/beta hydrolase superfamily, catalyze the terminal step of triglyceride (TAG) hydrolysis, converting monoacylglycerol (MAG) into free fatty acids and glycerol.
Zhibin Zhou +7 more
doaj +1 more source
Neuroinflammation, a hallmark of neurodegenerative diseases, is associated with neuronal cell loss and cognitive dysfunction. Monoacylglycerol lipase (MAGL) is involved in neuroinflammation in the brain via the degradation of endocannabinoid 2 ...
Naoto Arimura +10 more
doaj +1 more source
Δ9-Tetrahydrocannabinol (THC), the psychoactive component of marijuana, and other direct cannabinoid receptor (CB1) agonists produce a number of neurobehavioral effects in mammals that range from the beneficial (analgesia) to the untoward (abuse ...
Booker, L. +21 more
core +1 more source
Synthesis of benzoylpiperidine-based MAGL inhibitors as prospective anticancer agents
Monoacylglycerol lipase (MAGL) is a serine hydrolase enzyme involved in many biological processes, such as the degradation of 2-arachidonoylglycerol (2-AG), one of the most important endocannabinoid neurotransmitters.
LICARI, CRISTINA
core
Potenziale attività terapeutica degli inibitori della MAGL, enzima del sistema endocannabinoide
Il monoacilglicerolo lipasi (MAGL) è una serina idrolasi citosolica associata alla membrana, è espressa nel fegato e nel tessuto adiposo, ma la sua massima espressione è nel cervello, in particolare nelle regioni che comprendono il cervelletto, la ...
DAL CANTO, VALENTINA
core
Monoacylglycerol lipase (MAGL) is nowadays acknowledged as the main enzyme responsible for the deactivation of the most abundant brain endocannabinoid, 2-arachidonoylglycerol (2-AG).
FERRISI, REBECCA
core
Il lavoro di tesi ha previsto lo studio, in prima battuta, della monoacilglicerolo Lipasi (MAGL), una serina idrolasi che svolge un ruolo importante nella degradazione del 2-arachidonoilglicerolo (2-AG), neurotrasmettitore endocannabinoide coinvolto in ...
DI STEFANO, MIRIANA
core
Development of Glycoconjugated MAGL Inhibitors with Glucose-Dependent Antiproliferative Activity. [PDF]
Bononi G +10 more
europepmc +1 more source

